Compare HTCR & BMRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | HTCR | BMRA |
|---|---|---|
| Founded | 2009 | 1971 |
| Country | Japan | United States |
| Employees | N/A | N/A |
| Industry | EDP Services | Biotechnology: In Vitro & In Vivo Diagnostic Substances |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.5M | 6.3M |
| IPO Year | 2022 | 1995 |
| Metric | HTCR | BMRA |
|---|---|---|
| Price | $0.23 | $2.18 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 408.9K | 17.1K |
| Earning Date | 03-30-2026 | 04-13-2026 |
| Dividend Yield | ★ 57.73% | N/A |
| EPS Growth | ★ 66.67 | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $30,407,229.00 | $5,311,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $3.52 | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 39.19 | N/A |
| 52 Week Low | $0.22 | $0.40 |
| 52 Week High | $1.66 | $4.60 |
| Indicator | HTCR | BMRA |
|---|---|---|
| Relative Strength Index (RSI) | 38.86 | 51.49 |
| Support Level | $0.22 | $2.11 |
| Resistance Level | $0.26 | $2.23 |
| Average True Range (ATR) | 0.02 | 0.14 |
| MACD | -0.00 | 0.03 |
| Stochastic Oscillator | 13.74 | 80.75 |
HeartCore Enterprises Inc is a software development company. The company provides software through two business units. The first business unit includes a customer experience management business. The customer experience management platform includes marketing, sales, service, and content management systems, as well as other tools and integrations that enable companies to attract and engage customers throughout the customer experience. It also provides education, services and support to help customers be successful with the CXM Platform. The second business unit, DX division, is a digital transformation business that provides customers with robotics process automation, process mining, and task mining to accelerate the digital transformation of enterprises.
Biomerica Inc is engaged in the development, manufacturing, and marketing of medical diagnostic products designed for the early detection and monitoring of chronic diseases and medical conditions. The company focuses on products for gastrointestinal diseases, food intolerances, diabetes, and certain esoteric tests. The Company manages its operations as a single operating and reportable segment, which focus on the development, manufacture, marketing, and sale of diagnostic products. The majority of the company's revenue is earned from the Asia, and also has its presence in Europe, North America, Middle East and South America.